Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Brodbeck

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
Use of recombinant DAF proteins to localize the epitopes recognized by monoclonal anti-CD55W G Brodbeck, M E Medof
Immunology|September 30, 2000
Structure/function studies of human decay-accelerating factorW G Brodbeck, L Kuttner-Kondo, C Mold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attackW G Brodbeck, C Mold, J P Atkinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Localization of classical and alternative pathway regulatory activity within the decay-accelerating factorW G Brodbeck, D Liu, J Sperry, et al.
Journal of Biomedical Materials Research|April 5, 2001
Influence of biomaterial surface chemistry on the apoptosis of adherent cellsW G Brodbeck, M S Shive, E Colton, et al.
Cytokine|August 6, 2002
Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitroW G Brodbeck, Y Nakayama, T Matsuda, et al.
Clinical and Experimental Immunology|February 24, 2001
Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF)E Cocuzzi, L B Szczotka, W G Brodbeck, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
Use of recombinant DAF proteins to localize the epitopes recognized by monoclonal anti-CD55W G Brodbeck, M E Medof
Immunology|September 30, 2000
Structure/function studies of human decay-accelerating factorW G Brodbeck, L Kuttner-Kondo, C Mold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attackW G Brodbeck, C Mold, J P Atkinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Localization of classical and alternative pathway regulatory activity within the decay-accelerating factorW G Brodbeck, D Liu, J Sperry, et al.
Journal of Biomedical Materials Research|April 5, 2001
Influence of biomaterial surface chemistry on the apoptosis of adherent cellsW G Brodbeck, M S Shive, E Colton, et al.
Cytokine|August 6, 2002
Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitroW G Brodbeck, Y Nakayama, T Matsuda, et al.
Clinical and Experimental Immunology|February 24, 2001
Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF)E Cocuzzi, L B Szczotka, W G Brodbeck, et al.
Pageof 1